AMLX - Amylyx Pharmaceuticals Inc. (AMLX) Q1 2024 Earnings Call Transcript
2024-05-09 10:40:09 ET
Amylyx Pharmaceuticals, Inc. (AMLX)
Q1 2024 Results Conference Call
May 09, 2024 08:00 AM ET
Company Participants
Lindsey Allen - Head, IR & Communications
Justin Klee - Co-CEO
Camille Bedrosian - CMO
Jim Frates - CFO
Josh Cohen - Co-CEO
Conference Call Participants
Corinne Jenkins - Goldman Sachs
Graig Suvannavejh - Mizuho
Presentation
Operator
Good morning. My name is Morgan, and I will be your conference operator today. At this time, I would like to welcome everyone to the Amylyx Pharmaceuticals First Quarter 2024 Earnings Conference Call. All participants will be in a listen-only mode. After today's presentation, there will be an opportunity to ask questions. [Operator Instructions]. Please limit your questions to one with one follow-up. If you have additional questions, you may rejoin the queue. Please be advised that this call is being recorded at the company's request.
I would now like to turn the call over to your host, Lindsey Allen, Head of Investor Relations and Communications. Please proceed.
Lindsey Allen
Good morning, and thank you for joining us today to discuss our first quarter 2024 Financial results. With me on the call are Josh Cohen and Justin Klee, our Co-CEOs; Jim Frates, our Chief Financial Officer; and Dr. Camille Bedrosian, our Chief Medical Officer....
Amylyx Pharmaceuticals, Inc. (AMLX) Q1 2024 Earnings Call Transcript